These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 12784328

  • 1. Hepatic steatosis in patients with chronic hepatitis C virus infection. Another risk factor for hepatocellular carcinoma?
    Zhu AX, Chung RT.
    Cancer; 2003 Jun 15; 97(12):2948-50. PubMed ID: 12784328
    [No Abstract] [Full Text] [Related]

  • 2. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K.
    Cancer; 2003 Jun 15; 97(12):3036-43. PubMed ID: 12784339
    [Abstract] [Full Text] [Related]

  • 3. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR, Bhan AK, Zheng H, Chung RT.
    Cancer; 2007 Jun 15; 109(12):2490-6. PubMed ID: 17487861
    [Abstract] [Full Text] [Related]

  • 4. Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.
    Kumar D, Farrell GC, Kench J, George J.
    J Gastroenterol Hepatol; 2005 Sep 15; 20(9):1395-400. PubMed ID: 16105127
    [Abstract] [Full Text] [Related]

  • 5. NASH and HCC.
    Page JM, Harrison SA.
    Clin Liver Dis; 2009 Nov 15; 13(4):631-47. PubMed ID: 19818310
    [Abstract] [Full Text] [Related]

  • 6. [Steatosis and hepatitis C].
    Testino G.
    Recenti Prog Med; 2005 Dec 15; 96(12):621-33; quiz 654. PubMed ID: 16496750
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N, Rizzetto M.
    Minerva Gastroenterol Dietol; 2005 Mar 15; 51(1):31-46. PubMed ID: 15756144
    [Abstract] [Full Text] [Related]

  • 9. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G.
    Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330
    [Abstract] [Full Text] [Related]

  • 10. [Chronic hepatitis C, clinical course and risk of hepatocarcinoma].
    Rodríguez Lozano J, Castro Iglesias A, Pedreira Andrade J.
    An Med Interna; 2000 Jul 15; 17(7):339-42. PubMed ID: 10981328
    [No Abstract] [Full Text] [Related]

  • 11. Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.
    Acalovschi M.
    Rom J Gastroenterol; 2003 Jun 15; 12(2):123-30. PubMed ID: 12853999
    [No Abstract] [Full Text] [Related]

  • 12. Steatosis: co-factor in other liver diseases.
    Powell EE, Jonsson JR, Clouston AD.
    Hepatology; 2005 Jul 15; 42(1):5-13. PubMed ID: 15962320
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus-induced hepatocellular steatosis.
    Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM.
    Am J Gastroenterol; 2005 Mar 15; 100(3):711-5. PubMed ID: 15743372
    [Abstract] [Full Text] [Related]

  • 14. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M.
    J Gastroenterol Hepatol; 2008 Sep 15; 23(9):1431-6. PubMed ID: 18854000
    [Abstract] [Full Text] [Related]

  • 15. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
    Hsieh MH, Lee LP, Hsieh MY, Tsai KB, Huang JF, Hou NJ, Chen SC, Lin ZY, Hsieh MY, Wang LY, Dai CY, Chuang WL, Yu ML.
    Jpn J Infect Dis; 2007 Nov 15; 60(6):377-81. PubMed ID: 18032828
    [Abstract] [Full Text] [Related]

  • 16. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O.
    Clin Oncol (R Coll Radiol); 2007 Apr 15; 19(3):197-203. PubMed ID: 17359907
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma among hemodialysis patients infected with hepatitis C virus--early evolution and rapid progression.
    Hayashi H, Ohtake Y, Kashima T, Irie Y, Murata M, Hayashi H, Kobayashi S, Okuda K.
    Clin Nephrol; 1999 May 15; 51(5):321-3. PubMed ID: 10363635
    [No Abstract] [Full Text] [Related]

  • 18. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP, Younossi ZM.
    Clin Liver Dis; 2005 Nov 15; 9(4):617-34, vi. PubMed ID: 16207567
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C and steatosis.
    Björnsson E, Angulo P.
    Arch Med Res; 2007 Aug 15; 38(6):621-7. PubMed ID: 17613353
    [Abstract] [Full Text] [Related]

  • 20. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K, Tanaka Y, Orito E, Sugiyama M, Fujiwara K, Sugauchi F, Kato T, Tokita H, Izumi N, Kato M, Yuen MF, Lai CL, Gish RG, Ueda R, Mizokami M.
    Clin Infect Dis; 2006 Jan 01; 42(1):1-7. PubMed ID: 16323084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.